title: Modulation of oxidative events by multivalent manganese complexes in brain tissue.
abstract: Manganese toxicity can evoke neuropsychiatric and neuromotor symptoms, which have frequently been attributed to profound oxidative stress in the dopaminergic system. However, the characterization of manganese as a pro-oxidant remains controversial because antioxidant properties also have been associated with this metal. The current study was designed to address these disparate findings concerning the oxidative properties of manganese. The apparent ability of manganese in its divalent form to promote formation of reactive oxygen species (ROS) within a cortical mitochondrial-synaptosomal (P2) fraction was completely abolished by the addition of one five hundredth of its molarity of desferroxamine (DFO), a trivalent metal chelator. This large ratio and the high specificity of DFO for trivalent metal ions discounted the possibility of inhibition of ROS generation by direct sequestration of divalent manganese, and implied the trace presence of a trivalent metal. Further analysis suggested that this trace metal was manganic rather than ferric ion. Ferric ion was able to dampen the reactive oxygen species-generating capacity of manganous chloride, whereas manganic ion markedly promoted this property attributed to manganous ion. Such findings of the potent effects of trace amounts of trivalent cations upon Mn2+-related free radical generation offer resolution of earlier disparate findings concerning the oxidative character of manganese.
authors.affiliation: Department of Community and Environmental Medicine, Center for Occupational and Environmental Health, University of California, Irvine, Irvine, CA 92697-1825, USA. diemh@uci.edu
authors.forename: D
authors.initials: D
authors.lastname: HaMai
authors.forename: A
authors.initials: A
authors.lastname: Campbell
authors.forename: S C
authors.initials: SC
authors.lastname: Bondy
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D002412:Cations; D002413:Cations, Divalent; D002540:Cerebral Cortex / Q000648:ultrastructure; D002614:Chelating Agents / Q000494:pharmacology; D003676:Deferoxamine / Q000494:pharmacology; D005290:Ferric Compounds / Q000494:pharmacology; D005609:Free Radicals; D008297:Male; D008345:Manganese / Q000494:pharmacology*; D051379:Mice; D008928:Mitochondria / Q000378:metabolism; D016877:Oxidants / Q000494:pharmacology*; D010084:Oxidation-Reduction; D017382:Reactive Oxygen Species / Q000378:metabolism*; D013574:Synaptosomes / Q000378:metabolism
chemical_list: D000975:Antioxidants; D002412:Cations; D002413:Cations, Divalent; D002614:Chelating Agents; D005290:Ferric Compounds; D005609:Free Radicals; D016877:Oxidants; D017382:Reactive Oxygen Species; D008345:Manganese; D003676:Deferoxamine